MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

Search

Celsion Corp

Gesloten

0

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Belangrijke statistieken

By Trading Economics

Werknemers

25

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+2592.31% upside

Dividenden

By Dow Jones

Volgende Winsten

13 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.4M

12M

Vorige openingsprijs

0

Vorige sluitingsprijs

0

Celsion Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 jul 2025, 22:07 UTC

Belangrijke Marktbewegers

Trade Desk Rises on S&P 500 Inclusion

14 jul 2025, 17:06 UTC

Belangrijke Marktbewegers

Crypto Assets Rally Ahead of Possible U.S. Legislation

14 jul 2025, 16:47 UTC

Acquisities, Fusies, Overnames

NatWest to Sell Stake in Permanent TSB

14 jul 2025, 23:46 UTC

Marktinformatie

Nikkei May Rise as Yen Weakens -- Market Talk

14 jul 2025, 23:38 UTC

Marktinformatie

Gold Edges Higher Ahead of U.S. CPI Data -- Market Talk

14 jul 2025, 23:37 UTC

Marktinformatie

ANZ's Institutional Earnings Likely to Weigh on Outlook -- Market Talk

14 jul 2025, 23:29 UTC

Marktinformatie

South32 Bull Eyes Possible Last-Minute Power Deal for Mozal -- Market Talk

14 jul 2025, 23:29 UTC

Marktinformatie

Global Energy Roundup: Market Talk

14 jul 2025, 23:02 UTC

Winsten

China Vanke: Additional Provision for Asset Impairment Also Among Factors Weighing on Results >000002.SZ

14 jul 2025, 23:02 UTC

Winsten

China Vanke: Weakness in Overall China Real-Estate Sector Weighed on Results >000002.SZ

14 jul 2025, 23:02 UTC

Winsten

China Vanke 1H Loss Was CNY9.85B >000002.SZ

14 jul 2025, 23:01 UTC

Winsten

China Vanke Sees 1H Loss CNY10.0B-Loss CNY12.0B >000002.SZ

14 jul 2025, 23:01 UTC

Winsten

China Vanke Expects 1H Loss to Widen >000002.SZ

14 jul 2025, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

14 jul 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

14 jul 2025, 20:07 UTC

Marktinformatie

Cloud Computing Giants Will Be the Winner from Software's Loss -- Market Talk

14 jul 2025, 20:05 UTC

Marktinformatie

Adobe and Salesforce May Struggle to Keep Up With AI Agents -- Market Talk

14 jul 2025, 19:11 UTC

Marktinformatie

Oil Retreats Despite Trump Threats of Russia Sanctions -- Market Talk

14 jul 2025, 19:09 UTC

Marktinformatie

Gold Breaks a 3-Day Win Streak -- Market Talk

14 jul 2025, 18:59 UTC

Marktinformatie

Hotter Weather Outlook, LNG Flows Boost U.S. Natural Gas -- Market Talk

14 jul 2025, 18:30 UTC

Acquisities, Fusies, Overnames

Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close. -- Barrons.com

14 jul 2025, 18:25 UTC

Marktinformatie

Dollar Gains, Treasury Yields Lose Steam as Trump Threatens Russia -- Market Talk

14 jul 2025, 18:25 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

14 jul 2025, 16:59 UTC

Marktinformatie

Goldman Sachs Lifts 2H25 Crude Price Views -- Market Talk

14 jul 2025, 16:53 UTC

Populaire aandelen

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 jul 2025, 16:27 UTC

Marktinformatie

Oil Falls as Investors Monitor U.S.-EU Trade, Trump's Russia Sanction Threats -- Market Talk

14 jul 2025, 16:20 UTC

Marktinformatie
Winsten

Auto & Transport Roundup: Market Talk

14 jul 2025, 16:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

14 jul 2025, 16:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

14 jul 2025, 16:12 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

Peer Vergelijking

Prijswijziging

Celsion Corp Prognose

Koersdoel

By TipRanks

2592.31% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 14Ā USDĀ  2592.31%

Hoogste 14Ā USD

Laagste 14Ā USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Celsion Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Financieel

$

Over Celsion Corp

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.